Clinical Trials in Fuchu-shi, Japan

3 recruiting

Showing 19 of 9 trials

Recruiting
Phase 2Phase 3

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

Generalized Myasthenia Gravis
UCB Biopharma SRL12 enrolled14 locationsNCT06149559
Recruiting
Phase 3

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Systemic Lupus Erythematosus
AstraZeneca100 enrolled98 locationsNCT05835310
Recruiting

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia

Atrial FibrillationConcomitant ProceduresPFA+1 more
Boston Scientific Corporation433 enrolled34 locationsNCT06686485
Recruiting
Phase 3

Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

Osteogenesis Imperfecta
Amgen106 enrolled65 locationsNCT05972551
Recruiting
Phase 3

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

Hyperkalaemia
AstraZeneca140 enrolled69 locationsNCT03813407
Recruiting
Phase 3

Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)

Complex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring200 enrolled19 locationsNCT07094087
Recruiting
Phase 3

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Crohn's Disease
AbbVie110 enrolled83 locationsNCT06332534
Recruiting
Phase 3

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease
AbbVie110 enrolled85 locationsNCT05995353
Recruiting
Phase 3

Phase III Trial of Stage I Ovarian Cancer After Surgery

Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group360 enrolled103 locationsNCT04063527